Elizabeth Arden (RDEN) & DS Healthcare Group (DSKX) Head to Head Comparison

Elizabeth Arden (NASDAQ: RDEN) and DS Healthcare Group (NASDAQ:DSKX) are both non-cyclical consumer goods & services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, profitabiliy, valuation and analyst recommendations.

Institutional & Insider Ownership

70.7% of Elizabeth Arden shares are owned by institutional investors. Comparatively, 8.5% of DS Healthcare Group shares are owned by institutional investors. 15.2% of Elizabeth Arden shares are owned by insiders. Comparatively, 19.4% of DS Healthcare Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Elizabeth Arden and DS Healthcare Group, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elizabeth Arden 0 1 0 0 2.00
DS Healthcare Group 0 0 0 0 N/A

Elizabeth Arden currently has a consensus price target of $14.00, indicating a potential upside of 0.07%. Given Elizabeth Arden’s higher probable upside, research analysts clearly believe Elizabeth Arden is more favorable than DS Healthcare Group.

Profitability

This table compares Elizabeth Arden and DS Healthcare Group’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Elizabeth Arden -11.89% -135.03% -11.66%
DS Healthcare Group -54.89% -663.97% -86.80%

Volatility & Risk

Elizabeth Arden has a beta of 1.35, meaning that its share price is 35% more volatile than the S&P 500. Comparatively, DS Healthcare Group has a beta of 0.88, meaning that its share price is 12% less volatile than the S&P 500.

Earnings & Valuation

This table compares Elizabeth Arden and DS Healthcare Group’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Elizabeth Arden N/A N/A N/A ($2.49) -5.62
DS Healthcare Group N/A N/A N/A ($0.77) -0.08

Elizabeth Arden is trading at a lower price-to-earnings ratio than DS Healthcare Group, indicating that it is currently the more affordable of the two stocks.

Summary

Elizabeth Arden beats DS Healthcare Group on 6 of the 8 factors compared between the two stocks.

About Elizabeth Arden

Elizabeth Arden, Inc. is a global beauty products company with a portfolio of fragrance, skin care and cosmetics brands. The Company’s segments include North America and International. The Company’s North America segment sells its portfolio of owned, licensed and distributed brands, including the Elizabeth Arden products, to retailers, mass retailers and distributors in the United States, Canada and Puerto Rico, and also includes its direct to consumer business, which consists of its Elizabeth Arden branded retail outlet stores and its e-commerce business in North America. The Company’s North America segment also sells Elizabeth Arden products through the Red Door Spa beauty salons and spas. The Company’s International segment sells its portfolio of owned and licensed brands, including its Elizabeth Arden products, to perfumeries, boutiques, department stores, travel retail outlets and distributors in approximately 120 countries outside of North America.

About DS Healthcare Group

DS Healthcare Group, Inc., doing business as DS Laboratories, is a personal care, product development and marketing company. The Company develops and markets branded personal care products that address thinning hair conditions, skin care and other personal care needs. It develops technologies and products for hair care and personal care needs. Its technologies include Liposome Technology, which acts as a carrier agent, and is designed to enhance the act ion of the active ingredients in its products, and Nanosome Technology, which acts as a delivery vehicle, and is designed to infuse active compounds into targeted cells. The Company products are primarily sold under its DS Laboratories brand. It also sells certain products under its Polaris Labs and Sigma Skin brands. It markets and sells these products through salons, spas, department stores, specialty retailers and distributors. The Company offers products under three product categories: Hair Care, Skin Care and Personal Care.

Receive News & Ratings for Elizabeth Arden Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elizabeth Arden Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
Shares at Radius Jump as Bone Drug of Amgen Has Setback
Shares at Radius Jump as Bone Drug of Amgen Has Setback


© 2006-2017 Ticker Report. Google+.